Pyxis Oncology is trading 7.4% up today at $2.85, rebounding after Friday’s pullback and last week’s volatility.
- The move is being linked to short-term technical factors and a broader risk-on tone in U.S. equities rather than new company-specific news or fundamental developments.
- The stock appears to be moving in line with improving market sentiment and its typically elevated volatility profile.